davidstatcom david dodell subject hicn610 medical news part 44 cut limit azt efficacy suggest using drug either sequentially drug kind aid treatment cocktail combining number drug fight viru treating person azt alone doesnt happen real world anymore said dr mark jacobson university californiasan francisco also recent finding indicating hiv replicate rapidly lymph node infection physician may begin pushing even harder early treatment hivinfected patient new infectiou disease push american medical news 040593 vol 36 13 p 2 center disease control launch worldwide network track spread infectiou disease detect drugresistant new strain time help prevent spread network expected cost 75 million 125 million essential part clinton administration health reform plan according cdc outside expert plan require cdc enhance surveillance disease united state establish 15 facility acros world track disease april 13 1993 nih plan begin aid drug trial earlier stage nature 040193 vol 362 6419 p 382 macilwain colin hicnet medical newsletter page 42 volume 6 number 10 april 20 1993 national institute health ha announced start treating hivpositive patient soon possible seroconversion resulting recent finding show hiv active body large number much earlier wa previously believed anthony faucus director u national institute allergy infectiou disease niaid said must addres question treat person early possibly drug safe enough give person year get around microbial resistance said delay would signify question safety resistance rather lack fund faucus co authored one two paper published last week nature reject argument one hi coauthor cecil fox new discovery indicate 1 billion spent vaccine trial ha waste time money trial started long patient infected ended quickly john tew medical college virginium richmond claim new evidence strongly back argument early treatment hivinfected patient aid activist welcomed new information said scientific community ha slow understand significance infection lymph tissue weve known thi five year glad public domain said jesse dobson californiabased project inform peter duesberg believe aid independent hiv result drug abuse west said several paradox away explanation aidseven paper right april 14 1993 risk aid viru doctor found minimal washington post 041493 p a9 risk hiv transmitted infected healthcare professional patient minimal according new research published today journal american medical association jama thi finding support previou conclusion health expert chance contracting hiv health care worker remote three study jama demonstrate thousand patient treated two hivpositive surgeon dentist without becoming infected viru study conducted separate research team new hampshire maryland florida study started hivpositive doctor dentist tested patient willing participate new hampshire study found none 1174 patient undergone invasive procedure hivpositive orthopedic surgeon contracted hiv maryland 413 1131 patient operated breast surgery specialist john hopkin hospital found hivnegative similarly florida 900 1192 dental hicnet medical newsletter page 43 volume 6 number 10 april 20 1993 patient treated hivpositive general dentist tested found negative hiv florida researcher led gordon dickinson university miami school medicine said thi study indicate risk transmission hiv general dentist hi patient minimal setting universal precaution strictly observed related story philadelphium inquirer 0414 p a6 alternative medicine advocate divided new nih research program aid treatment news 040293 172 p 6 gilden dave new office alternative medicine national institute health ha raised question nih commitment effort use unorthodox holistic therapeutic method oam small division nih budget 2 million dollar compared 10 billion nih whole addition money available research grant even smaller 500000 600000 total available thi year 10 20 grant kaiya montaocean center natural traditional medicine washington dc say oam afraid become involved aid look successful easy answer aid said also common perception oam focu field nih establishment find nonthreatening relaxation technique acupuncture oam called advisory committee conference 120 person last year aid community wa largely missing meeting addition activist general lack contact office ha added suspicion epidemic ignored jon greenberg actupnew york said oam advisory panel composed practitioner without real research experience take several year accept nature research nevertheles dr leanna standish research director aid investigator bastyr college naturopathic medicine seattle said wonderful opportunity fund aid research fair give office time gel public insist much much public relation herpesviru decimate immunecell soldier science news 040393 vol 143 14 p 215 fackelmann kathy scientist conducting test tube experiment found herpesviru 6 attack human immune system natural killer cell thi attack cause killer cell malfunction diminishing important component immune system fight disease also herpesvirus6 may factor immune disease aid 1989 paolo lusso research found herpesvirus6 attack another white cell cd4 tlymphocyte primary target hiv lusso also found herpesvirus6 hicnet medical newsletter page 44 volume 6 number 10 april 20 1993 kill natural killer cell scientist previously knew natural killer cell patient infected hiv work correctly lusso research represent first time scientist indicated natural killer cell vulnerable kind viral attack according anthony l komaroff researcher harvard medical school despite testtube finding scientist uncertain whether result occur body lusso team also found herpesvirus6 produce cd4 receptor molecule provide acces hiv cd4 tlymphocyte expres thi surface receptor making vulnerable hiv attack researcher concluded herpesvirus6 cell exacerbate affect hiv april 15 1993 aid priority global village editor journal american medical association 040793 vol 269 13 p 1636 gellert george nordenberg dale f healthcare worker obligated responsible ensuring politician understand dimension certain health problem also committed related policy write george gellert dale f nordenberg orange county health care agency santum ana calif emory university school public health atlantum ga respectively dr berkley editorial american doctor care aid epidemic beyond united state detail several reason concerted interest country share combating aid noted aid lead hastening global health interdependence illnes disease malarium many respiratory intestinal pathogen similarly inhibited economic development humanity acted marginalize large population berkley mention enormou social economic impact aid many developing country increased need international assistance result berkley also cite lack political aggressivenes toward aid epidemic first decade new administration promise substantial difference approach international health development general hivaid particular vice president al gore propose hi book earth balance major environmental initiative include sustainable international development program promote literacy improve child survival disseminate contraceptive technology acces throughout developing world enacted thi change policy could drastically change future worldwide health aid priority global village reply journal american hicnet medical newsletter page 45 volume 6 number 10 april 20 1993 medical association 040793 vol 269 13 p 1636 berkley seth every nation tackle hiv early aggressively possible disease reach endemic state even cost diverting le attention illness write seth berkley rockefeller foundation new york ny reply letter dr gellert nordenberg although true disease aid malarium respiratory intestinal illness similarly inhibited economic development developing country deserve much attention getting berkley disagree contention aid receiving much attention hiv differ disease developing country continuing spread endemic disease outcome neglecting intervention one year another year level needle disease death aid increasing spread cost neglect disease burden financially much greater intervention early part rampantly spreading epidemic like hiv highly costeffective individual infection prevented significantly interrupt transmission berkley say agree gellert nordenberg gigantic social economic effect aid need political leadership conclude assertive political leadership needed united state aid epidemic even developing country high rate hiv infection complacency epidemic ha rule hicnet medical newsletter page 46 volume 6 number 10 april 20 1993 aidshiv article first hiv vaccine trial begin hivinfected child h h n e w u department health human service march 29 1993 first hiv vaccine therapy trial begin hivinfected child national institute health ha opened first trial experimental hiv vaccine child infected human immunodeficiency viru hiv viru cause aid trial compare safety three hiv experimental vaccine 90 child recruited least 12 site nationwide volunteer must hiv infected symptom hiv disease hh secretary donna e shalala said thi initial study seen hopeful milestone effort ameliorate tragedy hivinfected child face certainty develop aid anthony faucus md director national institute allergy infectiou disease nih office aid research said trial first step finding whether vaccine help prevent delay disease progression child hiv yet sick vaccine prove safe sophisticated question therapeutic potential assessed phase ius trial center disease control prevention estimate 10000 child united state hiv end decade world health organization project 10 million child infected worldwide study enroll child age 1 month 12 year old niaid fund aid clinical trial group network anticipate conducting trial nine actg site around country three site participating actg funded national institute child health human development preliminary evidence similar study way infected adult show certain vaccine boost existing hivspecific immune response hicnet medical newsletter page 47 volume 6 number 10 april 20 1993 stimulate new one several year however researcher know response affect clinical course disease result pediatric trial known actg 218 examined closely reason well thi trial provide first insight immature immune system respond candidate hiv vaccine said daniel hoth md director niaid division aid need thi information design trial test whether experimental vaccine prevent hiv infection child united state hivinfected child live poor innercity area 80 percent minority mainly black hispanic nearly hivinfected child acquire viru mother pregnancy birth infected mother united state ha one fmy chance transmitting viru baby growing number woman childbearing age become exposed hiv injection drug use infected sexual partner researcher expect corresponding increase number infected child hiv disease progress rapidly infant child adult recent information suggest 50 percent infant born hiv develop seriou aidsrelated infection 3 6 year age infection include severe frequent bout common bacterial illness childhood result seizure pneumonium diarrhea symptom leading nutritional problem long hospital stay least half child trial 2 year age younger enable comparison immune response younger older participant volunteer must welldocumented hiv infection symptom hiv disease swollen lymph gland mildly swollen liver spleen received antiretroviral immune regulating drug within one month prior entry study study chair john lambert md university rochester medical school co chair samuel katz md duke university school medicine coordinate trial assisted jame mcnamara md medical officer pediatric medicine branch niaid division aid compare safety vaccine closely monitoring child side effect see one vaccine produce swollen arm fever example another said dr mcnamara well also look whether low high dose vaccine stimulate immune response significant laboratory clinical effect emphasized small study size preclude comparing response effect among three hicnet medical newsletter page 48 volume 6 number 10 april 20 1993 product trial test two dose three experimental vaccine made recombinant hiv protein socalled subunit vaccine genetically engineered contain piece viru far proved well tolerated ongoing trial hivinfected adult one vaccine made microgenesy inc meriden conn contain gp160a protein gife rise hiv surface proteinsplu alum adjuvant adjuvant boost specific immune response vaccine presently alum adjuvant used human vaccine licensed food drug administration vaccinesone made genentech inc south san francisco biocine joint venture chiron cibageigy emeryville califcontain major hiv surface protein gp120 plu adjuvant genentech vaccine contain alum biocine vaccine contain mf59 experimental adjuvant ha proved safe effective phase vaccine trial adult low dose product tested first placebo 15 child twelve child assigned random immunized experimental vaccine three child given adjuvant alone considered placebo neither health care worker child told receive low dose welltolerated controlled testing higher dose experimental vaccine adjuvant placebo another group 15 child begin child receive six immunizationsone every fmy week six monthsand followedup 24 week last immunization information trial site eligibility enrollment call aid clinical trial information service 1800trialsa 9 7 pm est weekday service ha spanishspeaking information specialist available information niaid pediatric hivaid research available office communication 301 496 5717 nih cdc fda agency u public health service hh pres inquiry please call laurie k doepel 301 4021663 hicnet medical newsletter page 49 volume 6 number 10 april 20 1993 new evidence hiv cause disease independently news national institute dental research new evidence human immunodeficiency viru cause disease independently ability suppres immune system say scientist national institue health report hiv opportunistic infection caused scaling skin condition develop mouse carrying gene hiv although hiv gene active mouse compromise animal immunity researcher found thi led conclude hiv caused skin disease finding support growing body evidence hiv cause disease without affecting immune system said lead author dr jeffrey kopp national institute dental research nidr dr kopp hi colleague described study march issue aid research human retroviruse developing animal model hiv infection ha difficult since animal including mouse infected viru bypas thi problem scientist developed hivtransgenic mouse carry gene hiv well genetic material nidr scientist created transgenic mouse injecting hiv gene mouse egg implanting egg female mouse resulting litter contained normal transgenic animal institute scientist created mouse carried complete copy hiv genetic material l988 mouse however became sick died soon birth study depth present study scientist used incomplete copy hiv allowed animal live longer transgenic animal developed scaling wartlike tumor neck back transgenic mouse developed thickened crusting skin lesion covered body resembling psoriasi human skin lesion developed normal nontransgenic littermate study tissue taken wartlike skin tumor showed type noncancerou tumor called papilloma although papillomaviru cause skin lesion laboratory test showed sign viru animal tissue sample taken sick mouse throughout study revealed presence proteinproducing molecule made hiv genetic material hicnet medical newsletter page 50 volume 6 number 10 april 20 1993 evidence hiv protein production proved viral gene turned active said dr kopp scientist found evidence however compromised immunity mouse increase white blood cell count sign common infection fact hiv gene active animal immune system suppressed confirm viru wa causing skin lesion dr kopp said proof hiv gene involvement came test scientist exposed transgenic animal ultraviolet light light increased hiv genetic activity causing papilloma develop formerly healthy skin papilloma formation response increased hiv genetic activity proved gene responsible skin condition scientist said lesion appeared normal mouse exposed uv light transgenic mouse used thi study developed nidr dr peter dickie national institute allergy infectiou disease collaborating study dr kopp mr charle wohlenberg dr nickola dorfman joseph bryant abner notkin paul klotman nidr dr stephen katz national cancer institute dr jame rooney formerly nidr burrough wellcome hicnet medical newsletter page 51 volume 6 number 10 april 20 1993 clinical consultation telephone service aid h h n e w u department health human service march 4 1993 hh secretary donna e shalala today announced first nationwide clinical consultation telephone service doctor health care professional question providing care person hiv infection aid tollfree national hiv telephone consulting service staffed physician nurse practitioner pharmacist provide information drug clinical trial latest treatment method service funded health resource service administration operate san francisco general hospital secretary shalala said one goal thi project share expertise patient get best care second goal get primary health care provider involved care person hiv aid reduce treatment cost allowing patient remain medical provider community social support network currently many provider refer patient hiv aid specialist provider experience secretary shalala said thi clinical expertise especially helpful physician provider treat person hiv aid community clinical site hiv expertise readily available telephone number health care professional 18009333413 accessible 1030 8 pm est 730 5 pm pst monday friday time consultant try answer question immediately within hmy time physician health care provider leave electronic message question answered quickly possible health care professional may call service ask question related providing hiv care including latest hivaid drug treatment information clinical trial information subspecialty case referral literature search information service designed health care professional rather patient family alternate source information material health care professional call new service call taken either clinical pharmacist primary care physician family nurse practitioner staff member extensive experience outpatient inpatient primary care person hivrelated disease consultant ask patientspecific information including cd4 cell count current medication sex age patient hiv history thi national service ha grown 16month local effort hicnet medical newsletter page 52 volume 6 number 10 april 20 1993 responded nearly 1000 call health care provider northern californium initial project wa funded hrsa bureau health profession community provider aid training cpat project american academy family physician provider expand knowledge also improve quality care able provide patient said hrsa administrator robert g harmon md mph thi project great resource health care professional hivaid patient serve thi service ha opened new mean communication health care professional expert hiv care management said hrsa associate administrator aid director bureau health resource development g stephen bowen md mph provider treat person hiv aid acces latest information new drug treatment method therapy person hiv aid hrsa one eight u public health service agency within hh aid hotline number consumer cdc national aid hotline 1800342aid information spanish 1800344sida aid clinical trial english spanish 1800trialsa hicnet medical newsletter page 53 cut thi last part internet davidstatcom fax 1 602 4511165 bitnet atw1hasuacad fidonet 111415 amateur packet ax25 wb7tpywb7tpyazusana